|
Volumn 6, Issue 1, 2014, Pages 126-131
|
Combination studies of platinum(ii)-based metallointercalators with buthionine-S,R-sulfoximine, 3-bromopyruvate, cisplatin or carboplatin
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LIGANDS;
PLATINUM COMPOUNDS;
ADVERSE SIDE EFFECTS;
ANTI-PROLIFERATIVE ACTIVITIES;
ANTICANCER ACTIVITIES;
CHEMOTHERAPEUTIC TREATMENTS;
COMBINATION THERAPY;
ORGANIC MOLECULES;
SYNERGISTIC COMBINATIONS;
THERAPEUTIC EFFICACY;
PLATINUM;
BROMOPYRUVIC ACID;
BUTHIONINE SULFOXIMINE;
CARBOPLATIN;
CISPLATIN;
PYRUVIC ACID DERIVATIVE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
ANTIPROLIFERATIVE ACTIVITY;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG CYTOTOXICITY;
DRUG EFFICACY;
DRUG POTENTIATION;
DRUG SAFETY;
DRUG STRUCTURE;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IC 50;
OVARY CARCINOMA;
PRIORITY JOURNAL;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BUTHIONINE SULFOXIMINE;
CARBOPLATIN;
CELL LINE;
CELL LINE, TUMOR;
CELL SURVIVAL;
CISPLATIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG SYNERGISM;
GLUTATHIONE;
HUMANS;
INHIBITORY CONCENTRATION 50;
MOLECULAR STRUCTURE;
NEOPLASMS;
ORGANOPLATINUM COMPOUNDS;
PLATINUM;
PYRUVATES;
|
EID: 84890960576
PISSN: 17565901
EISSN: 1756591X
Source Type: Journal
DOI: 10.1039/c3mt00191a Document Type: Article |
Times cited : (23)
|
References (36)
|